HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma.

AuthorsThomas D Rodgers, Andrea Baran, Patrick M Reagan, Carla Casulo, Clive Zent, Andrew Evans, Richard Burack, AnnaLynn M Williams, Jonathan W Friedberg, Paul M Barr
JournalBritish journal of haematology (Br J Haematol) Vol. 188 Issue 4 Pg. e33-e36 (02 2020) ISSN: 1365-2141 [Electronic] England
PMID31845324 (Publication Type: Letter)
Chemical References
  • Lenalidomide
Topics
  • Aged
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Lenalidomide (administration & dosage)
  • Lymphoma, Large B-Cell, Diffuse (drug therapy, mortality)
  • Male
  • Middle Aged
  • Risk Factors
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: